SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017437
Filing Date
2022-08-15
Accepted
2022-08-15 17:49:58
Documents
80
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q srne-20220630.htm   iXBRL 10-Q 3539791
2 EX-31.1 srne-ex31_1.htm EX-31.1 16328
3 EX-31.2 srne-ex31_2.htm EX-31.2 16743
4 EX-32.1 srne-ex32_1.htm EX-32.1 25545
  Complete submission text file 0000950170-22-017437.txt   12160447

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srne-20220630_def.xml EX-101.DEF 306505
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srne-20220630_lab.xml EX-101.LAB 566548
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srne-20220630.xsd EX-101.SCH 69355
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srne-20220630_cal.xml EX-101.CAL 71128
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srne-20220630_pre.xml EX-101.PRE 456217
74 EXTRACTED XBRL INSTANCE DOCUMENT srne-20220630_htm.xml XML 2363374
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 221167181
SIC: 2836 Biological Products, (No Diagnostic Substances)